New antiviral drug cuts cytomegalovirus infection, improves survival in patients undergoing donor stem cell transplant
In a significant advance in improving the safety of donor stem cell transplants, a major clinical trial has shown that a novel agent can protect against the most common viral infection that patients face after transplantation.
Source: ScienceDaily Headlines - Category: Science Source Type: news
More News: Clinical Trials | Cytomegalovirus | Science | Stem Cell Therapy | Stem Cells | Transplant Surgery | Transplants